Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? Academic Article Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • On the basis of the results of this study, no significant difference in outcome exists between patients with Stage I-II endometrial cancer with PS/CC histologic features and those with similar stage disease, but with FIGO Grade 3 endometrioid histologic features. CSLI was the only independent predictor of poor DFS and OS.

publication date

  • September 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0360-3016(02)02913-9

PubMed ID

  • 12182977

Additional Document Info

start page

  • 79

end page

  • 85

volume

  • 54

number

  • 1